{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:59Z","timestamp":1790959259787,"version":"4.1.0"},"reference-count":137,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NCI\/NIH","award":["R21CA179652"],"award-info":[{"award-number":["R21CA179652"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Triple negative breast cancer (TNBC) is a difficult to treat disease due to the absence of the three unique receptors estrogen, progesterone and herceptin-2 (HER-2). To improve the current therapy and overcome the resistance of TNBC, there is unmet need to develop an effective targeted therapy. In this regard, one of the logical and economical approaches is to develop a tumor hypoxia-targeting drug formulation platform for selective delivery of payload to the drug-resistant and invasive cell population of TNBC tumors. Toward this, we developed a Carbonic Anhydrase IX (CA IX) receptor targeting human serum albumin (HSA) carriers to deliver the potent anticancer drug, Paclitaxel (PTX). We used Acetazolamide (ATZ), a small molecule ligand of CA IX to selectively deliver HSA-PTX in TNBC cells. A novel method of synthesis involving copper free \u2018click\u2019 chemistry (Dibenzocyclooctyl, DBCO) moiety with an azide-labeled reaction partner, known as Strain-Promoted Alkyne Azide Cycloaddition (SPAAC) along with a desolvation method for PTX loading were used in the present study to arrive at the CA IX selective nano-carriers, HSA-PTX-ATZ. The anticancer effect of HSA-PTX-ATZ is higher compared to HSA, PTX and non-targeted HSA-PTX in MDA-MB-231 and MDA-MB-468 cells. The cell killing effect is associated with induction of early and late phases of apoptosis. Overall, our proof-of-concept study shows a promising avenue for hypoxia-targeted drug delivery that can be adapted to several types of cancers.<\/jats:p>","DOI":"10.3390\/ijms19030838","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T13:37:21Z","timestamp":1520948241000},"page":"838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Copper-Free \u2018Click\u2019 Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-968X","authenticated-orcid":false,"given":"Katyayani","family":"Tatiparti","sequence":"first","affiliation":[{"name":"Use-Inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4364-5875","authenticated-orcid":false,"given":"Samaresh","family":"Sau","sequence":"additional","affiliation":[{"name":"Use-Inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh","family":"Gawde","sequence":"additional","affiliation":[{"name":"Use-Inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4428-0222","authenticated-orcid":false,"given":"Arun","family":"Iyer","sequence":"additional","affiliation":[{"name":"Use-Inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA"},{"name":"Molecular Imaging Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"ref_1","unstructured":"(2015). CDC Expected New Cancer Cases and Deaths in 2020, Centers for Disease Control and Prevention."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sau, S., Alsaab, H.O., Bhise, K., Alzhrani, R., Nabil, G., and Iyer, A.K. (2018). Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment. J. Control. Release.","DOI":"10.1016\/j.jconrel.2018.01.028"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yang, X., Iyer, A.K., Singh, A., Milane, L., Choy, E., Hornicek, F.J., Amiji, M.M., and Duan, Z. (2015). Cluster of differentiation 44 targeted hyaluronic acid based nanoparticles for MDR1 siRNA delivery to overcome drug resistance in ovarian cancer. Pharm. Res., 32.","DOI":"10.1007\/s11095-014-1602-1"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wickens, J.M., Alsaab, H.O., Kesharwani, P., Bhise, K., Amin, M.C.I.M., Tekade, R.K., Gupta, U., and Iyer, A.K. (2017). Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov. Today, 22.","DOI":"10.1016\/j.drudis.2016.12.009"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/acs.biomac.6b01885","article-title":"Polyvalent folate-dendrimer-coated iron oxide theranostic nanoparticles for simultaneous magnetic resonance imaging and precise cancer cell targeting","volume":"18","author":"Luong","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.colsurfb.2017.06.025","article-title":"Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers","volume":"157","author":"Luong","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.colsurfb.2015.09.043","article-title":"Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells","volume":"136","author":"Kesharwani","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/acs.biomac.5b00941","article-title":"Hyaluronic acid engineered nanomicelles loaded with 3,4-difluorobenzylidene curcumin for targeted killing of CD44+ stem-like pancreatic cancer cells","volume":"16","author":"Kesharwani","year":"2015","journal-title":"Biomacromolecules"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1021\/mp500024p","article-title":"Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors","volume":"11","author":"Iyer","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2013.10.016","article-title":"In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles","volume":"172","author":"Ganesh","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ganesh, S., Iyer, A.K., Weiler, J., Morrissey, D.V., and Amiji, M.M. (2013). Combination of siRNA-directed gene silencing with cisplatin reverses drug resistance in human non-small cell lung cancer. Mol. Ther. Nucleic Acids, 2.","DOI":"10.1038\/mtna.2013.29"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Choudhury, H., Gorain, B., Pandey, M., Kumbhar, S.A., Tekade, R.K., Iyer, A.K., and Kesharwani, P. (2017). Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int. J. Pharm., 529.","DOI":"10.1016\/j.ijpharm.2017.07.018"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/acs.molpharmaceut.5b00827","article-title":"In vivo antitumor activity of folate-conjugated cholic acid-polyethylenimine micelles for the codelivery of doxorubicin and sirna to colorectal adenocarcinomas","volume":"12","author":"Amjad","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Alsaab, H., Alzhrani, R., Kesharwani, P., Sau, S., Boddu, S., and Iyer, A. (2017). Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9020015"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1021\/ar2000106","article-title":"Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery","volume":"44","author":"Abeylath","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104928","DOI":"10.18632\/oncotarget.20650","article-title":"A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma","volume":"8","author":"Cheriyan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ejmech.2017.07.027","article-title":"Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues","volume":"138","author":"Almansour","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1039\/c4nr00974f","article-title":"Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle","volume":"6","author":"Sau","year":"2014","journal-title":"Nanoscale"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Susa, M., Iyer, A.K., Ryu, K., Choy, E., Hornicek, F.J., Mankin, H., Milane, L., Amiji, M.M., and Duan, Z. (2010). Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010764"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sau, S., Mondal, S.K., Kashaw, S.K., Iyer, A.K., and Banerjee, R. (2017). Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: A strategy for repurposing a phase I clinical trial drug. Mol. Cell. Biochem., 436.","DOI":"10.1007\/s11010-017-3084-z"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.bmc.2017.06.038","article-title":"pH responsive biodegradable nanogels for sustained release of bleomycin","volume":"25","author":"Sahu","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sahu, P., Das, D., Kashaw, V., Iyer, A.K., and Kashaw, S.K. (2017). Nanogels: A New Dawn in Antimicrobial Chemotherapy, Elsevier.","DOI":"10.1016\/B978-0-323-52733-0.00005-7"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcis.2016.08.061","article-title":"Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures","volume":"484","author":"Luong","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Luong, D., Kesharwani, P., Deshmukh, R., Mohd Amin, M.C.I., Gupta, U., Greish, K., and Iyer, A.K. (2016). PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Acta Biomater., 1\u201316.","DOI":"10.1016\/j.actbio.2016.07.015"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Khan, I., Gothwal, A., Sharma, A.K., Kesharwani, P., Gupta, L., Iyer, A.K., and Gupta, U. (2016). PLGA nanoparticles and their versatile role in anticancer drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 33.","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015273"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.exphem.2008.06.002","article-title":"Targeting of heat-shock protein 32\/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis","volume":"36","author":"Hadzijusufovic","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gleixner, K.V., Mayerhofer, M., Vales, A., Gruze, A., H\u00f6rmann, G., Cerny-Reiterer, S., Lackner, E., Hadzijusufovic, E., Herrmann, H., and Iyer, A.K. (2009). Targeting of Hsp32 in solid tumors and leukemias: A novel approach to optimize anticancer therapy. Curr. Cancer Drug Targets, 9.","DOI":"10.2174\/156800909789057024"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcis.2017.01.092","article-title":"Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue","volume":"496","author":"Gawde","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.biomaterials.2013.01.077","article-title":"Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors","volume":"34","author":"Ganesh","year":"2013","journal-title":"Biomaterials"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijpharm.2017.04.078","article-title":"Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach","volume":"526","author":"Bhise","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bhise, K., Sau, S., Alsaab, H., Kashaw, S.K., Tekade, R.K., and Iyer, A.K. (2017). Nanomedicine for cancer diagnosis and therapy: Advancement, success and structure-activity relationship. Ther. Deliv., 8.","DOI":"10.4155\/tde-2017-0062"},{"key":"ref_32","unstructured":"Amiji, M.M., and Iyer, A.K. (2015). Multifunctional Self-Assembling Polymeric Nanosystems. (US 9,173,840), United States Patent."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/1061186X.2013.832769","article-title":"Multifunctional nanoparticles for targeting cancer and inflammatory diseases","volume":"21","author":"Jain","year":"2013","journal-title":"J. Drug Target."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1021\/ja044996f","article-title":"A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems","volume":"126","author":"Agard","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16793","DOI":"10.1073\/pnas.0707090104","article-title":"Copper-free click chemistry for dynamic in vivo imaging","volume":"104","author":"Baskin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/bi9007726","article-title":"Click chemistry and bioorthogonal reactions: Unprecedented selectivity in the labeling of biological molecules","volume":"48","author":"Best","year":"2009","journal-title":"Biochemistry"},{"key":"ref_37","unstructured":"Gundluru, M. (2018). Custom Synthesis of Strained Cyclooctyne-Peptide Conjugates for Copper-Free Click Chemistry, Peptides International, Inc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1039\/b901970g","article-title":"Cu-free click cycloaddition reactions in chemical biology","volume":"39","author":"Jewett","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: Diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov. Today"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/adma.200602739","article-title":"Click chemistry: Versatility and control in the hands of materials scientists","volume":"19","author":"Nandivada","year":"2007","journal-title":"Adv. Mater."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1021\/cr200409f","article-title":"Click chemistry for drug development and diverse chemical-biology applications","volume":"113","author":"Thirumurugan","year":"2013","journal-title":"Chem. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.tetlet.2015.03.136","article-title":"New click-chemistry methods for 1,2,3-triazoles synthesis: Recent advances and applications","volume":"56","author":"Totobenazara","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2017.03.023","article-title":"Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies","volume":"253","author":"Sahu","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Iyer, A.K., Su, Y., Feng, J., Lan, X., Zhu, X., Liu, Y., Gao, D., Seo, Y., VanBrocklin, H.F., and Courtney Broaddus, V. (2011). The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma. Biomaterials, 32.","DOI":"10.1016\/j.biomaterials.2010.11.073"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.2174\/1381612821666150803152033","article-title":"Nano-constructed carriers loaded with antioxidant: Boon for cardiovascular system","volume":"21","author":"Jain","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ng, K.E., Amin, M.C.I.M., Katas, H., Amjad, M.W., Butt, A.M., Kesharwani, P., and Iyer, A.K. (2016). pH-responsive triblock copolymeric micelles decorated with a cell-penetrating peptide provide efficient doxorubicin delivery. Nanoscale Res. Lett., 11.","DOI":"10.1186\/s11671-016-1755-4"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mahor, A., Prajapati, S.K., Verma, A., Gupta, R., Iyer, A.K., and Kesharwani, P. (2016). Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in vitro, in vivo evaluation. J. Colloid Interface Sci., 483.","DOI":"10.1016\/j.jcis.2016.08.018"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000165380","article-title":"Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases","volume":"46","author":"Daruwalla","year":"2009","journal-title":"J. Vasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Daruwalla, J., Greish, K., Nikfarjam, M., Millar, I., Malcontenti-Wilson, C., Iyer, A.K., and Christophi, C. (2007). Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA mice. J. Drug Target., 15.","DOI":"10.1080\/10611860701499839"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Susa, M., Iyer, A.K., Ryu, K., Hornicek, F.J., Mankin, H., Amiji, M.M., and Duan, Z. (2009). Doxorubicin loaded polymeric nanoparticulate delivery system to overcome drug resistance in osteosarcoma. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-399"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Kobayashi, E., Iyer, A.K., Hornicek, F.J., Amiji, M.M., and Duan, Z. (2013). Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: A pilot study basic research. Clin. Orthop. Relat. Res., 471.","DOI":"10.1007\/s11999-012-2610-2"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.colsurfb.2015.05.007","article-title":"Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer","volume":"132","author":"Kesharwani","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.progpolymsci.2016.09.008","article-title":"Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy","volume":"64","author":"Amjad","year":"2017","journal-title":"Prog. Polym. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.addr.2013.07.012","article-title":"Role of integrated cancer nanomedicine in overcoming drug resistance","volume":"65","author":"Iyer","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2174\/092986712800784685","article-title":"Image-guided nanosystems for targeted delivery in cancer therapy","volume":"19","author":"Iyer","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Singh, A., Iyer, A.K., Amiji, M., and Ganta, S. (2013). Multifunctional Nanosystems for Cancer Therapy, Elsevier.","DOI":"10.1533\/9780857096760.3.387"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Iyer, A., Ganta, S., and Amiji, M. (2010). Polymeric Nanoparticles as Target-Specific Delivery Systems, Pan Stanford.","DOI":"10.1201\/9780429111570-2"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Patel, R., Patel, M., Kwak, J., Iyer, A.K., Karpoormath, R., Desai, S., and Rarh, V. (2017). Polymeric microspheres: A delivery system for osteogenic differentiation. Polym. Adv. Technol., 28.","DOI":"10.1002\/pat.4084"},{"key":"ref_60","first-page":"2913","article-title":"Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Iyer, A.K., Greish, K., Seki, T., Okazaki, S., Fang, J., Takeshita, K., and Maeda, H. (2007). Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation. J. Drug Target., 15.","DOI":"10.1080\/10611860701498252"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.biomaterials.2006.11.051","article-title":"High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor","volume":"28","author":"Iyer","year":"2007","journal-title":"Biomaterials"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Tatiparti, K., Sau, S., Kashaw, S., and Iyer, A. (2017). siRNA delivery strategies: A comprehensive review of recent developments. Nanomaterials, 7.","DOI":"10.3390\/nano7040077"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.drudis.2014.12.012","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_65","unstructured":"Iyer, A.K., and Ave, M. (2016). Rational Design of Multifunctional Nanoparticles for Targeted Cancer Imaging and Therapy. Post-Genomic Approaches in Cancer and Nano Medicine, River Publishers."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/bit.21578","article-title":"Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment","volume":"99","author":"Hyung","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.msec.2016.09.052","article-title":"Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics","volume":"70","author":"Huang","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2015.09.042","article-title":"Targeting tumor metastases: Drug delivery mechanisms and technologies","volume":"219","author":"Ganapathy","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.biomaterials.2009.02.045","article-title":"Poly(lactide)-vitamin E derivative\/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel","volume":"30","author":"Feng","year":"2009","journal-title":"Biomaterials"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/adhm.201200467","article-title":"Multifunctional albumin nanoparticles as combination drug carriers for intra-tumoral chemotherapy","volume":"2","author":"Cui","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"18504","DOI":"10.18632\/oncotarget.4181","article-title":"Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells","volume":"6","author":"Basak","year":"2015","journal-title":"Oncotarget"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addr.2014.05.005","article-title":"Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment","volume":"79","author":"Kanapathipillai","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.10.041","article-title":"Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity","volume":"403","author":"Kim","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1002\/anie.201001356","article-title":"Self-assembly of thermally responsive amphiphilic diblock copolypeptides into spherical micellar nanoparticles","volume":"49","author":"Kim","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nchem.2749","article-title":"A polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165)","volume":"9","author":"Koide","year":"2017","journal-title":"Nat. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpharm.2017.01.037","article-title":"Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine","volume":"519","author":"Mohammadi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1007\/s11095-009-9955-6","article-title":"Fluorocurcumins as cyclooxygenase-2 inhibitor: Molecular docking, pharmacokinetics and tissue distribution in mice","volume":"26","author":"Padhye","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.colsurfb.2016.02.053","article-title":"Stimuli-responsive poly (N-isopropyl acrylamide)-co-tyrosine@ gadolinium: Iron oxide nanoparticle-based nanotheranostic for cancer diagnosis and treatment","volume":"142","author":"Roy","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcis.2010.10.024","article-title":"Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo","volume":"354","author":"Song","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1021\/acs.molpharmaceut.5b00218","article-title":"Selective tumor targeting of desacetyl vinblastine hydrazide and tubulysin b via conjugation to a cholecystokinin 2 receptor (CCK2R) ligand","volume":"12","author":"Wayua","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzym. Regul."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: Is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.ddtec.2011.11.010","article-title":"Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: Are we there yet?","volume":"9","author":"Greish","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-409X(00)00134-4","article-title":"SMANCS and polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy","volume":"46","author":"Maeda","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.18632\/oncotarget.2065","article-title":"Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals","volume":"5","author":"Gatti","year":"2014","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2014.06.051","article-title":"Cationic lipid-conjugated dexamethasone as a selective antitumor agent","volume":"83","author":"Sau","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Sau, S., Alsaab, H.O., Kashaw, S.K., Tatiparti, K., and Iyer, A.K. (2017). Advances in antibody?drug conjugates: A new era of targeted cancer therapy. Drug Discov. Today.","DOI":"10.1016\/j.drudis.2017.05.011"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(03)00134-0","article-title":"Optimization of the preparation process for human serum albumin (HSA) nanoparticles","volume":"257","author":"Langer","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.bjc.6690708","article-title":"The asialoglycoprotein receptor in human hepatocellular carcinomas: Its expression on proliferating cells","volume":"81","author":"Fiume","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(00)00590-1","article-title":"Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups","volume":"211","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22804","DOI":"10.1074\/jbc.M100575200","article-title":"Crystal structure analysis of warfarin binding to human serum albumin. Anatomy of drug site I","volume":"276","author":"Petitpas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery\u2014New applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-3659(03)00302-X","article-title":"Human serum albumin-polyethylenimine nanoparticles for gene delivery","volume":"92","author":"Rhaese","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0005-2736(99)00238-2","article-title":"Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum","volume":"1463","author":"Simoes","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: Harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol. Cell. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jddst.2017.03.017","article-title":"Bovine serum albumin-based nanoparticles containing resveratrol: Characterization and antioxidant activity","volume":"39","author":"Fonseca","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Casini","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_105","unstructured":"Pastorekova, S., and Pastorek, J. (2004). Carbonic Anhydrase, Its Inhibitors and Activators, CRC Press."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/14756366.2013.848205","article-title":"Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression","volume":"29","author":"Sneddon","year":"2014","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_108","first-page":"221","article-title":"Chapter 13: Carbonic Anhydrase IX as an Imaging and Therapeutic Target for Tumors and Metastases","volume":"Volume 75","author":"Tafreshi","year":"2014","journal-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/bi0523409","article-title":"Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation","volume":"45","author":"Mohan","year":"2006","journal-title":"Biochemistry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/jm9902638","article-title":"Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle","volume":"42","author":"Owa","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_111","unstructured":"Schrier, R.W. (1976). Renal and Electrolyte Disorders, Little Brown and Co."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02659120","article-title":"Sulfonamide inhibitors of carbonic anhydrase inhibit the growth of human lymphoma cells in culture","volume":"3","author":"Chegwidden","year":"1995","journal-title":"Inflammopharmacology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","article-title":"Albumin-bound paclitaxel: A next-generation taxane","volume":"7","author":"Gradishar","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/17435889.2.4.415","article-title":"Nanoparticle albumin-bound paclitaxel: A novel Cremphor-EL\u00ae-free formulation of paclitaxel","volume":"2","author":"Stinchcombe","year":"2007","journal-title":"Nanomedicine"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/js9605226","article-title":"Solid-state characterization of paclitaxel","volume":"86","author":"Liggins","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1634\/theoncologist.3-6-373","article-title":"Paclitaxel in Breast Cancer","volume":"3","author":"Perez","year":"1998","journal-title":"Oncologist"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"19413","DOI":"10.18632\/oncotarget.4989","article-title":"Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition","volume":"6","author":"Ledaki","year":"2015","journal-title":"Oncotarget"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/10715760600730810","article-title":"Cobalt induces hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism","volume":"40","author":"Triantafyllou","year":"2006","journal-title":"Free Radic. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1166\/jbn.2016.2141","article-title":"Green synthesis and characterization of monodispersed gold nanoparticles: Toxicity study, delivery of doxorubicin and its bio-distribution in mouse model","volume":"12","author":"Mukherjee","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1039\/B613014N","article-title":"The growing applications of click chemistry","volume":"36","author":"Moses","year":"2007","journal-title":"Chem. Soc. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.addr.2008.02.004","article-title":"Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne \u201cclick\u201d chemistry","volume":"60","author":"Lutz","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11307-015-0885-x","article-title":"Evaluation of CAIX and CAXII expression in breast cancer at varied O2Levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia","volume":"18","author":"Tafreshi","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2004.08.017","article-title":"Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate","volume":"100","author":"Yoo","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/138161208783877893","article-title":"Cancer-associated carbonic anhydrases and their inhibition","volume":"14","author":"Pastorekova","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/187152009788680028","article-title":"Inhibition of carbonic anhydrase IX: A new strategy against cancer","volume":"9","author":"Winum","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/med.20112","article-title":"Carbonic anhydrase IX: A new druggable target for the design of antitumor agents","volume":"28","author":"Winum","year":"2008","journal-title":"Med. Res. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0968-0896(00)00288-1","article-title":"Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents?","volume":"9","author":"Supuran","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/bi0523409","article-title":"Antimitotic sulfonamide inhibit microtubule assembly dynamics & anticancer","volume":"45","author":"Panda","year":"2006","journal-title":"Biochemistry"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.colsurfb.2014.09.028","article-title":"Systematic study on the preparation of BSA nanoparticles","volume":"123","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/2230-973X.82432","article-title":"Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer","volume":"1","author":"Jithan","year":"2011","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-014-2635-1","article-title":"Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells","volume":"75","author":"Ivanova","year":"2015","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/3\/838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:56:52Z","timestamp":1760194612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/3\/838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":137,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["ijms19030838"],"URL":"https:\/\/doi.org\/10.3390\/ijms19030838","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]}}}